Clinical Trials recently completed a Phase 3 clinical trial to study the use of BSN175 as a treatment for Type 2 diabetes.


Pre-Clinical Pipeline

In addition to its lead program, Biospherics is applying its expertise and research to create a pipeline of proprietary candidates across a range of therapeutic indications.

See also: